homocysteine has been researched along with omapatrilat in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Robinson, K | 1 |
| MacMahon, S; Neal, B; Ohkubo, T; Tonkin, A; Wilcken, D | 1 |
| Brnabic, A; MacMahon, S; Neal, B; Ohkubo, T; Tonkin, A | 1 |
2 trial(s) available for homocysteine and omapatrilat
| Article | Year |
|---|---|
Dose-dependent effects of folic acid on plasma homocysteine in a randomized trial conducted among 723 individuals with coronary heart disease.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Australia; Biomarkers; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Folic Acid; Follow-Up Studies; Hematinics; Homocysteine; Humans; Male; Middle Aged; New Zealand; Pyridines; Thiazepines; Time Factors; Treatment Outcome | 2002 |
Effects of the vasopeptidase inhibitor, omapatrilat, in 723 patients with coronary heart disease.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Endothelins; Female; Homocysteine; Humans; Male; Middle Aged; Neurotransmitter Agents; Protease Inhibitors; Pyridines; Thiazepines | 2002 |
1 other study(ies) available for homocysteine and omapatrilat
| Article | Year |
|---|---|
Homocysteine and vascular disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Coronary Disease; Dose-Response Relationship, Drug; Folic Acid; Hematinics; Homocysteine; Humans; Pyridines; Thiazepines; Vascular Diseases | 2002 |